Literature DB >> 9153487

Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia.

T Ansved1, T Odergren, K Borg.   

Abstract

Previous electrophysiologic studies on the effects of local injections of botulinum toxin type A (BTX-A) have indicated impaired neuromuscular transmission in distant muscles. To further study possible distant effects of repeated BTX-A injections, we obtained percutaneous muscle biopsies of the vastus lateralis muscle from 11 patients with cervical dystonia. We examined the biopsies with histopathology and morphometry, and compared them with age-matched healthy controls. There was an increased frequency of angular atrophic type IIB fibers in the patient group, and the mean size of IIB fibers was significantly smaller (p < 0.05). In addition, there was a negative correlation between accumulated dose of botulinum toxin and relative size of type IIA fibers (p < 0.05). We postulate that the observed atrophy is due to distant effects of botulinum toxin causing progressive denervation-like changes in non-treated muscle. This observation calls for further, prospective studies of the long-term effects of the treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153487     DOI: 10.1212/wnl.48.5.1440

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Cervical Dystonia (Torticollis).

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

Review 2.  Cervical dystonia pathophysiology and treatment options.

Authors:  M Velickovic; R Benabou; M F Brin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety.

Authors:  Wilhelm J Schulte-Mattler
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 4.  Nonoperative management of spasticity in children.

Authors:  Susan Ronan; Joan T Gold
Journal:  Childs Nerv Syst       Date:  2007-07-24       Impact factor: 1.475

5.  Ultrastructural evaluation of intramuscular applied botulinum toxin type A in striated muscles of rats.

Authors:  H Kocaelli; M Yaltirik; M Ayhan; F Aktar; B Atalay; S Yalcin
Journal:  Hippokratia       Date:  2016 Oct-Dec       Impact factor: 0.471

6.  Assessing adverse effects of intra-articular botulinum toxin A in healthy Beagle dogs: A placebo-controlled, blinded, randomized trial.

Authors:  Helka M Heikkilä; Tarja S Jokinen; Pernilla Syrjä; Jouni Junnila; Anna Hielm-Björkman; Outi Laitinen-Vapaavuori
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

7.  S100 and p65 expression are increased in the masseter muscle after botulinum toxin-A injection.

Authors:  Young-Wook Park; Seong-Gon Kim; You-Young Jo
Journal:  Maxillofac Plast Reconstr Surg       Date:  2016-08-26

8.  Reduction of adhesion formation after knee surgery in a rat model by botulinum toxin A.

Authors:  Zheng-Yu Gao; Ji-Xia Wu; Wei-Bo Liu; Jin-Ke Sun
Journal:  Biosci Rep       Date:  2017-04-20       Impact factor: 3.840

9.  The use of botulinum toxin for the treatment of overactive bladder syndrome.

Authors:  Bogdan Orasanu; Sangeeta T Mahajan
Journal:  Indian J Urol       Date:  2013-01

Review 10.  Botulinum toxin type A: implications in wound healing, facial cutaneous scarring, and cleft lip repair.

Authors:  Mohammad M Al-Qattan; Bisher Nawras Al-Shanawani; Feras Alshomer
Journal:  Ann Saudi Med       Date:  2013 Sep-Oct       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.